Company news

Stevanato Group S.p.A. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Stevanato Group and Aptar Pharma Collaborate to Help Accelerate Pre-Filled Syringe System Selection

October 27, 2026

Stevanato Group to Report Third Quarter 2026 Financial Results on November 3, 2026

October 20, 2026

Stevanato Group to Participate in Two Upcoming Investor Conferences

September 8, 2026

Stevanato Group Delivers 8% Revenue Growth for the Second Quarter of Fiscal 2026

August 4, 2026

Liraglutide Combination Products Incorporating Stevanato Group's Alina® Pen Injector Received Marketing Authorizations in Multiple European Countries

July 30, 2026

Stevanato Group to Report Second Quarter 2026 Financial Results on August 4, 2026

July 21, 2026

Stevanato Group Introduces Deora™, a Pen Injector for Subcutaneous Delivery in Diabetes and Weight Management

June 8, 2026

Stevanato Group Announces Results of Ordinary and Extraordinary Shareholders’ Meeting

June 3, 2026

Stevanato Group Delivers 7% Revenue Growth (10% at Constant Currency) for the First Quarter of Fiscal 2026

May 7, 2026

Stevanato Group to Participate in Three Upcoming Investor Conferences

May 4, 2026

Stevanato Group to Report First Quarter 2026 Financial Results on May 7, 2026

April 23, 2026

Stevanato Group Delivers 7% Revenue Growth for Fiscal Year 2025, Including Record Revenue from High-Value Solutions and Expanded Margins

March 5, 2026

Stevanato Group Delivers 7% Revenue Growth (9% at Constant Currency) for Fiscal Year 2025, Including Record Revenue from High-Value Solutions and Expanded Margins

March 4, 2026

Stevanato Group to Report Fourth Quarter and Fiscal Year 2025 Financial Results on March 4, 2026

February 19, 2026

Stevanato Group Reports Revenue of €303.2 Million for the Third Quarter of 2025

November 6, 2025

Stevanato Group to Participate in Upcoming Investor Conferences

October 31, 2025

Stevanato Group to Report Third Quarter 2025 Financial Results on November 6, 2025

October 22, 2025

Stevanato Group Expands Drug Delivery Systems Capacity to Strengthen Global Integrated Offerings

October 21, 2025

Stevanato Group Reports Revenue of €280.0 Million for the Second Quarter of 2025

August 5, 2025

Stevanato Group Secures €200 Million in Financing from BNL BNP Paribas, Cassa Depositi e Prestiti, and Banco BPM to Fund Ongoing CAPEX Investments in Italy and the U.S.

July 23, 2025

Stevanato Group to Report Second Quarter 2025 Financial Results on August 5, 2025

July 22, 2025

Stevanato Group Reports Revenue of €256.6 Million for the First Quarter of 2025

May 8, 2025

Stevanato Group to Report First Quarter 2025 Financial Results on May 8, 2025

April 24, 2025

Stevanato Group to Participate in the KeyBanc Capital Markets Virtual Healthcare Forum

March 11, 2025

Stevanato Group Reports Record Revenue of €1,104 Million for Fiscal Year 2024

March 6, 2025

Stevanato Group to Report Fourth Quarter and Fiscal Year 2024 Financial Results on March 6, 2025

February 24, 2025

Calls

The 5 newest of 16 calls. Every call is listed under its year.

Decks

The 5 newest of 24 decks. Every deck is listed under its year.